ALKS as of Oct 31 · 11:16 ET
ALKSNasdaqPharmaceutical Preparations
Alkermes plc. · Brief
Next report
No upcoming report date.
Expected move
No implied move.
0 of 8≥ implied
- avg implied
- ±8.7%
- avg realized
- ±4.1%
May 1 '25±7.4%▲+6.29%×0.85
Jul 29 '25±9.3%▲+3.25%×0.35
Oct 22 '25±10.5%▼−1.14%×0.11
Oct 28 '25±11.0%▲+4.31%×0.39
Jan 12 '26±5.8%▼−0.13%×0.02
Q1 FY26±8.6%▼−7.04%×0.82
May 5 '26±7.3%▲+6.09%×0.83
Q2 FY26±9.8%▼−4.23%×0.43
quarterimplied−15%0+15%realized×
Q2 FY26±9.8%▼−4.23%×0.43
May '26±7.3%▲+6.09%×0.83
Q1 FY26±8.6%▼−7.04%×0.82
Jan '26±5.8%▼−0.13%×0.02
Oct '25±11.0%▲+4.31%×0.39
Oct '25±10.5%▼−1.14%×0.11
2 older reports
Jul '25±9.3%▲+3.25%×0.35
May '25±7.4%▲+6.29%×0.85
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
—
Linked exposure
ALKS report sessionCustomers 1
× = co-movement · max 499dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.